Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-095643
Filing Date
2016-02-04
Accepted
2016-02-04 11:58:46
Documents
2
Period of Report
2016-01-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2228
2 POA DOCUMENT poa.txt EX-24.3_630032 3308
  Complete submission text file 0001209191-16-095643.txt   6910
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3721 VALLEY CENTRE DR SUITE 500 SAN DIEGO CA 92130
Business Address
ACE HEATHER S (Reporting) CIK: 0001610762 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33415 | Film No.: 161387477